| Virginia B Geddes, APRN-CNM | |
|
1237 Alameda St, Norman, OK 73071-3006 | |
| (405) 632-6688 | |
| (405) 329-5711 |
| Full Name | Virginia B Geddes |
|---|---|
| Gender | Female |
| Speciality | |
| Experience | Years |
| Location | 1237 Alameda St, Norman, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093227506 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | 63858 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Virginia B Geddes, APRN-CNM 3000 N Grand Blvd, Oklahoma City, OK 73107-1818 Ph: (405) 632-6688 | Virginia B Geddes, APRN-CNM 1237 Alameda St, Norman, OK 73071-3006 Ph: (405) 632-6688 |
News Archive
New research from the University of Georgia finds that older Mexican Americans who live in low English-speaking neighborhoods are at greater risk for poor health and even an early death.
Shire plc has announced that data from a 12-month study of DAYTRANATM (methylphenidate transdermal system), the Attention Deficit Hyperactivity Disorder (ADHD) patch, demonstrated that DAYTRANA provided significant ADHD tolerability and symptom control improvement in children aged 6 to 12 years.
A study which looked at activity levels before and during the COVID-19 pandemic has found lockdown restrictions significantly reduced light activity associated with socializing and work.
The chronic inflammatory disease systemic lupus erythematosus, is about nine times more common in women than men, and a University of Houston researcher now has the money to find out why.
The drug, ladostigil, is a molecule that combines components from the existing drugs Azilect and Exelon. Teva's Azilect, for the treatment of Parkinson's disease, was developed by Prof. Emeritus Moussa Youdim of the Technion-Israel Institute of Technology. Azilect is the only anti-Parkinson's drug that has proven to have a disease-modifying effect. Novartis's Exelon was developed by Prof. Marta Weinstock-Rosin of Hebrew University to treat Alzheimer's disease.
› Verified 3 days ago
Katherine Edgmon, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 250 12th Ave Ne, Norman, OK 73071 Phone: 405-321-4048 |